The Chief Commercial Officer Summit, organized by Dynamic Global Events (“DGE”), returns to Philadelphia, PA, this fall. The 3rd Chief Commercial Officer Summit is scheduled for October 23-24, 2024, taking on a hybrid format. The in-person event is being held at The Inn at Penn – Hilton Hotel, conveniently located just six miles from the Philadelphia International Airport. Organizers will also be streaming the event live to a virtual audience, with the online option also allowing attendees to follow the sessions whenever and wherever on demand.
The 3rd Chief Commercial Officer Summit is expected to bring together leaders and professionals in the biotech, pharma, and medical device and diagnostics sectors. And, as the annual meeting place for chief commercial officers (“CCOs”), the summit promises to introduce professionals to market leaders making a difference in their respective spaces.
Additionally, the event forms an ideal setting for attendees to learn about the fundamental vision and out-of-box strategies for driving commercial growth and operational excellence. The summit will examine the potential impact of the 2024 presidential election on the life sciences industry; discuss the skills, capabilities and processes for moving from clinical to commercial; the CCO career path; and it will also look into how M&A or shifts in leadership can transform organizational culture.
Attendees will also gain insight into when to independently navigate the market, engage in co-promotion, or fully out-license assets, as well as how to integrate a commercial perspective into clinical trial recruitment to enhance communications. Moreover, they will learn about ways to negotiate market access with channel partners such as payers, wholesalers, distributors, and pharmacy benefit managers (“PBMs”).
With a lineup of distinguished speakers drawn from companies in the biopharma and medical devices spaces, and multiple opportunities to network, the two-day event is the best opportunity to gain insights, establish relationships, and generate fresh ideas. This list of speakers includes the likes of Christina Larkin, CEO of Mobius Care; Geoff Birkett, CCO of Ensysce Biosciences; Charmaine Lykins, a Commercial Strategy Advise and former CCO of MapLight Therapeutics; John Harlow, CCO of Melinta Therapeutics; and Ferrell Simon, CCO of Trevi, just to mention a few.
The summit kicks off early on October 23 with opening remarks from Robert Francomano, CCO of Synox Therapeutics, followed by a presentation titled “Potential Impact of 2024 Presidential Election on the Life Sciences Industry” by Jason Slotnik, Partner at Health Policy Strategies. The next item on the agenda will be a fireside chat, followed by a networking refreshment break, with attendees then returning for additional educational presentations, a second fireside chat, and a panel discussion summarizing CCO best practices. The second day is equally jam-packed, with a cocktail of insightful presentations and networking sessions that are all curated around this year’s theme: Vision and Strategy for Driving Commercial Growth and Excellence.
To learn more, visit https://ibn.fm/V4lww
